Wuhan Thalys Med Tech Co Ltd (603716) - Total Liabilities

Latest as of March 2026: CN¥753.10 Million CNY ≈ $110.20 Million USD

Based on the latest financial reports, Wuhan Thalys Med Tech Co Ltd (603716) has total liabilities worth CN¥753.10 Million CNY (≈ $110.20 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Wuhan Thalys Med Tech Co Ltd growing its equity to track the company's year-over-year net asset growth rate.

Wuhan Thalys Med Tech Co Ltd - Total Liabilities Trend (2011–2025)

This chart illustrates how Wuhan Thalys Med Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Wuhan Thalys Med Tech Co Ltd (603716) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Wuhan Thalys Med Tech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wuhan Thalys Med Tech Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Shenzhen CDL Precision Technology Co Ltd
SHE:300686
China CN¥1.07 Billion
Bar Harbor Bankshares Inc
NYSE MKT:BHB
USA $4.14 Billion
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
China CN¥88.79 Million
Log-In Logística Intermodal S.A
SA:LOGN3
Brazil R$2.76 Billion
CCP Contact Probe Co Ltd
TWO:6217
Taiwan NT$3.50 Billion
BTQ Technologies Corp.
NEO:BTQ
Canada CA$2.77 Million
Sharda Motor Industries Limited
NSE:SHARDAMOTR
India Rs7.49 Billion
H&R Century Union Corp
SHE:000892
China CN¥709.02 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Wuhan Thalys Med Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Wuhan Thalys Med Tech Co Ltd (603716) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.73 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Thalys Med Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Thalys Med Tech Co Ltd (2011–2025)

The table below shows the annual total liabilities of Wuhan Thalys Med Tech Co Ltd from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥897.96 Million
≈ $131.40 Million
-51.93%
2024-12-31 CN¥1.87 Billion
≈ $273.35 Million
-7.85%
2023-12-31 CN¥2.03 Billion
≈ $296.63 Million
-17.28%
2022-12-31 CN¥2.45 Billion
≈ $358.58 Million
-3.93%
2021-12-31 CN¥2.55 Billion
≈ $373.24 Million
+21.24%
2020-12-31 CN¥2.10 Billion
≈ $307.85 Million
+51.79%
2019-12-31 CN¥1.39 Billion
≈ $202.82 Million
+44.80%
2018-12-31 CN¥957.21 Million
≈ $140.07 Million
+69.23%
2017-12-31 CN¥565.62 Million
≈ $82.77 Million
+142.55%
2016-12-31 CN¥233.19 Million
≈ $34.12 Million
+20.85%
2015-12-31 CN¥192.97 Million
≈ $28.24 Million
+46.65%
2014-12-31 CN¥131.58 Million
≈ $19.25 Million
+43.30%
2013-12-31 CN¥91.82 Million
≈ $13.44 Million
-0.51%
2012-12-31 CN¥92.30 Million
≈ $13.51 Million
+53.18%
2011-12-31 CN¥60.25 Million
≈ $8.82 Million
--

About Wuhan Thalys Med Tech Co Ltd

SHG:603716 China Diagnostics & Research
Market Cap
$580.19 Million
CN¥3.96 Billion CNY
Market Cap Rank
#11471 Global
#3223 in China
Share Price
CN¥17.56
Change (1 day)
+4.59%
52-Week Range
CN¥13.40 - CN¥36.40
All Time High
CN¥45.48
About

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis sy… Read more